IM Transcend Testing and Cutover Lead Analyst
Date de publication :
19 octobre 2024Taux d'activité :
100%Type de contrat :
Durée indéterminée- Lieu de travail :Mühlacker
J&J Innovative Medicine, a member of Johnson & Johnson's Family of Companies, is recruiting for an IM Transcend Testing and Cutover Lead Analyst to join their team. The preferred location for this role is in Titusville, NJ. Consideration may be granted for other J&J work sites including Raritan NJ; New Brunswick NJ; Horsham PA; Spring House PA; Malvern PA; Markham Ontario & Toronto Canada. Additional locations include Switzerland, the UK, Ireland, and Belgium. The opportunity for remote work will be considered on a case-by-case basis.
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.
For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.
We know that the success of our business – and our ability to deliver meaningful solutions – depends on how well we understand and meet the diverse needs of the communities we serve. Which is why we foster a culture of inclusion and belonging where all perspectives, abilities and experiences are valued, and our people can reach their potential. At Johnson & Johnson, we all belong.
Innovative Medicines Transcend is a global business transformation program that will modernize our foundational transactional processes and harmonize them into a single ERP as a standardized platform for growth and efficiency gains.
The program will simplify the Innovative Medicines ERP landscape from 7 to 1, standardizing processes to have a digital backbone that is fit for purpose, allowing us to support the business with agility. Additionally, the program will remediate the end-of-life system exposure that we risk towards the end of this decade.
The Testing and Cutover Lead Analyst is part of the Innovative Medicines Transcend Finance Deployment Team; responsible for implementation of the E2E future state Finance processes as part of the S4/HANA implementation within the global transformation programs. This position will assist with all deployment release testing cycles, cutover planning, and execution as well as help drive overall Transcend program methodologies through the Finance Deployment Organization.
Responsibilities:
Anticipated workload split is 60% Testing Lead 40% Cutover Lead
Testing Lead Responsibilities:
- Support System Integration, Business Simulation, and User Acceptance Testing for all deployment releases
- Partner closely with the SigniFi Transact team to orchestrate joint end to end testing between the two systems
- Partner with functional workstream leads to develop end-to-end testing plans for each cycle
- Report on testing progress, risks, and issue resolution
- Partner with cross functional teams to ensure that all test data and transactions are ready prior to testing kick-off
- Assist in the triage of testing defects for proper disposition and resolution
- Assist in coordinating tester security and role access to ensure uninterrupted testing
Cutover Responsibilities:
- Support the development of comprehensive end to end cutover plans for each deployment release
- Support the cutover execution and tracking for each deployment release
- Support mock cutover cycles in preparation for go-live releases